Premium
Newly diagnosed diffuse large B ‐cell lymphoma benefit from the addition of thymosin alpha 1 to R‐CHOP : A propensity matched study from single institution
Author(s) -
Huang H.,
Xia Y.,
Gao Y.,
Wang X.,
Bai B.,
Cai Q.,
Zhao W.,
Yan Z.,
Li P.,
Lin T.,
Xia Z.,
Li Z.,
Jiang W.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2439_83
Subject(s) - chop , medicine , diffuse large b cell lymphoma , rituximab , thymosin , regimen , lymphoma , population , gastroenterology , propensity score matching , oncology , environmental health